Finally, we observed a significant increase in p-RIPK1 and p-MLKL staining via immunohistochemistry (IHC) in tumor samples from xenograft mice treated in vivo with SRF231 (Fig. 2I and J, staining controls displayed in Suppl. The gene discussed is MLKL; the disease is neoplasm.